“shire” Archives

in
Entry Author Date Location
Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists 08/28/17 Boston
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Shire Sets Sights on Dry Eye Disease with Deal for Parion Drug 05/01/17 Boston
His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? 02/16/17 New York
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod 11/28/16 New York
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo 10/21/16 National
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
With New Name and $47M, Proclara Begins First Big Alzheimer’s Test 09/07/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy 07/28/16 National
Merck, Amgen Invest in Akili as Therapeutic Video Game Moves Ahead 07/20/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree 03/22/16 New York
Armed With $30M, Akili Plans Bigger Trial of Therapeutic Video Game 01/22/16 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Still Eyeing Baxalta, Shire Pulls Trigger on $6.5B Dyax Buyout 11/02/15 Boston
Amid Nobel Prize Suspense, Making Sense Of Latest Gene-Editing News 10/06/15 National
West Coast Biotech Roundup: Amgen, Grizzlies, Topol, Faraday & More 09/03/15 San Francisco
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug 08/31/15 Boston
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher 08/31/15 New York
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal 08/03/15 New York
Page 1 of 5 next page »